Elucidating Lung Cancer Etiology Among Asian American Female Never Smokers
阐明从不吸烟的亚裔美国女性肺癌病因
基本信息
- 批准号:10307055
- 负责人:
- 金额:$ 65.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-02-01 至 2024-11-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdenocarcinomaAffectAgeAir PollutantsAsiaAsianAsian AmericansAttentionBody SizeCaliforniaCancer EtiologyCase-Control StudiesCessation of lifeChineseCommunicable DiseasesDataData SetDiagnosisEast AsianEnvironmental EpidemiologyEpidermal Growth Factor ReceptorEthnic OriginEthnic groupEtiologyExposure toFemaleFrequenciesGeneticHistologyHormone useIncidenceIndividualInterventionJapaneseJointsKoreansLow PrevalenceMalignant NeoplasmsMalignant neoplasm of lungMedical OncologyMethodsMolecular EpidemiologyMutationNormal tissue morphologyNot Hispanic or LatinoOilsPathway interactionsPopulationPopulation StudyPrevention strategyReproductive HistoryResearchRiskRisk FactorsScienceSmokeSmokingSmoking HistorySocial EnvironmentSomatic MutationTestingTissue SampleUnited StatesWomanambient air pollutionbaseburden of illnesscancer epidemiologycancer health disparitycancer riskcase controlcohortcommunity engaged researchcookingdesigndisease disparityexome sequencinggenomic datahealth inequalitieshormone therapyimprovedindoor concentrationsindoor pollutantneoplasm registrynever smokernever smokingnovelpopulation basedracial and ethnicsmoking prevalencesocial epidemiologytrendtumor
项目摘要
Abstract
Lung cancer in never smokers (LCINS) is a disease and disparity that disproportionately affects Asian American (AA)
females. In contrast to declining incidence trends seen among most racial/ethnic groups, incidence of lung cancer,
especially adenocarcinoma, has been increasing in most AA ethnic groups. The majority of AA females, upwards of
nearly 90% among Chinese, diagnosed with lung cancer have never smoked. There is very little known of the
contributing risk factors to the high and increasing incidence rates of LCINS among AA females, particularly as risk
factors identified in studies in Asia may have limited significance among AA populations. Moreover, there is limited
understanding of the relationships between the mutational signatures of tumors among this population and their
associated risk factors. Such information will improve our understanding of the underlying potential mechanistic
pathways. Thus, the overall objective of this study is to identify the attributable risk of known, putative, and suspected
risk factors for lung cancer among AA female never smokers. Recognizing that currently there are no U.S. datasets
nor existing cohorts with data for evaluating putative and suspected risk factors that may be most relevant to this
population, we propose a robust, population-based case-control study, leveraging early-case ascertainment methods
from cancer registries and tested state-of-the-science approaches for unbiased control ascertainment. With high-
quality, multilevel data collected from an estimated 600 female AA never-smoker lung cancer cases and 600
ethnicity and age frequency-matched controls, we aim to: Aim 1a. Identify risk factors for LCINS among AA females,
with attention to differences by histology and EGFR (epidermal growth factor receptor) status (determined using
whole exome sequencing [WES]), and focusing on multi-level factors including: a) genetic ancestry; b) individual-
level exposures, including putative and suspected risk factors; and c) contextual-level risk factors including indoor
and ambient air pollutants and the social environment, with consideration of nativity and years in the U.S. versus
Asia; Aim 1b. Determine the independent and joint contributions of multi-level risk factors to LCINS among AA
females by calculating the attributable risk for each risk factor, individually and in total; Aim 2a. Characterize the
mutational landscape of LCINS among AA females, through WES of paired tumor-normal tissue samples to define
somatic mutation profiles, mutational signatures, and EGFR status of LCINS AA females; and Aim 2b. Identify multi-
level risk factors associated with the major mutational tumor features. All aims will assess potential differences by
EGFR status. The proposed research will involve the assembly of the largest population-based lung cancer case-
control dataset, with associated genetic and tumor genomic data, for never-smoking AA women. It will provide a first-
ever opportunity to evaluate detailed multilevel factors contributing to the lung cancer disparity in distinct AA ethnic
groups. A clear understanding of the etiologic factors underlying the high and increasing lung cancer risk among AA
never-smoker females is necessary for designing the appropriate prevention strategies to reduce their high burden of
disease.
摘要
从不吸烟者的肺癌(LCINS)是一种不成比例地影响亚裔美国人(AA)的疾病和差异
女性。与大多数种族/族裔群体的发病率下降趋势相反,肺癌的发病率,
尤其是腺癌,在大多数AA民族中一直呈上升趋势。大多数AA女性,以上
在被诊断患有肺癌的中国人中,近90%的人从不吸烟。我们对此知之甚少
导致再生障碍性贫血女性发病率高且不断增加的危险因素,特别是作为危险因素
在亚洲的研究中发现的因素对再生障碍性贫血人群的意义可能有限。此外,有有限的
了解这一人群中肿瘤突变特征与其之间的关系
相关的风险因素。这些信息将提高我们对潜在机制的理解
小路。因此,本研究的总体目标是确定已知的、推定的和可疑的归因风险
AA女性从不吸烟者患肺癌的危险因素。认识到目前没有美国的数据集
也没有现有的队列数据来评估可能与此最相关的推定和疑似风险因素
人口,我们提出了一个强有力的,以人口为基础的病例对照研究,利用早期病例确定方法
来自癌症登记和经过测试的科学状态方法,以进行无偏见的控制确定。带着高-
高质量的多层次数据收集自估计600例女性戒烟协会从不吸烟的肺癌病例和600例
种族和年龄频率匹配的对照,我们的目标是:目标1a。在再生障碍性贫血女性中确定LC IN的危险因素,
注意组织学和EGFR(表皮生长因子受体)状态的差异(使用
整个外显子组测序[WES]),并关注多水平的因素,包括:a)遗传祖先;b)个体-
暴露水平,包括推定的和可疑的风险因素;以及c)背景水平的风险因素,包括室内
以及环境空气污染物和社会环境,考虑到出生和在美国的年份与
亚洲;目标1b。确定AA中多层次风险因素对LCINS的独立贡献和联合贡献
通过计算每个风险因素的归因风险,分别和全部计算女性;目标2a。描述一下
通过配对肿瘤-正常组织样本的WES来确定AA女性中LC IN的突变景观
LCINS AA雌性的体细胞突变谱、突变特征和EGFR状态;以及Aim 2b。确定多个-
与主要突变肿瘤特征相关的危险因素水平。所有AIMS将通过以下方式评估潜在差异
EGFR状态。拟议的研究将涉及收集最大的以人群为基础的肺癌病例-
对照数据集,以及相关的遗传和肿瘤基因组数据,用于从不吸烟的再生障碍性贫血妇女。它将提供第一个-
是否有机会评估导致不同AA种族肺癌差异的详细多水平因素
组。明确再生障碍性贫血患者肺癌高危和高危的病因
从不吸烟的女性是必要的,以制定适当的预防策略,以减轻她们的高负担
疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Moon Shao-Chuang Chen其他文献
Moon Shao-Chuang Chen的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Moon Shao-Chuang Chen', 18)}}的其他基金
Elucidating Lung Cancer Etiology Among Asian American Female Never Smokers
阐明从不吸烟的亚裔美国女性肺癌病因
- 批准号:
10527364 - 财政年份:2020
- 资助金额:
$ 65.19万 - 项目类别:
Elucidating Lung Cancer Etiology Among Asian American Female Never Smokers
阐明从不吸烟的亚裔美国女性肺癌病因
- 批准号:
10093129 - 财政年份:2020
- 资助金额:
$ 65.19万 - 项目类别:
Elucidating Lung Cancer Etiology Among Asian American Female Never Smokers
阐明从不吸烟的亚裔美国女性肺癌病因
- 批准号:
9885673 - 财政年份:2020
- 资助金额:
$ 65.19万 - 项目类别:
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
AANCART:国家减少亚裔美国人癌症健康差异中心
- 批准号:
8330980 - 财政年份:2010
- 资助金额:
$ 65.19万 - 项目类别:
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
AANCART:国家减少亚裔美国人癌症健康差异中心
- 批准号:
8535317 - 财政年份:2010
- 资助金额:
$ 65.19万 - 项目类别:
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
AANCART:国家减少亚裔美国人癌症健康差异中心
- 批准号:
8911948 - 财政年份:2010
- 资助金额:
$ 65.19万 - 项目类别:
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
AANCART:国家减少亚裔美国人癌症健康差异中心
- 批准号:
8732604 - 财政年份:2010
- 资助金额:
$ 65.19万 - 项目类别:
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
AANCART:国家减少亚裔美国人癌症健康差异中心
- 批准号:
8396709 - 财政年份:2010
- 资助金额:
$ 65.19万 - 项目类别:
AANCART: The National Center for Reducing Asian American Cancer Health Disparitie
AANCART:国家减少亚裔美国人癌症健康差异中心
- 批准号:
8536087 - 财政年份:2010
- 资助金额:
$ 65.19万 - 项目类别:
相似国自然基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
- 批准号:30840003
- 批准年份:2008
- 资助金额:12.0 万元
- 项目类别:专项基金项目
相似海外基金
Synergistic Radiosensitization of Hypoxic Pancreatic Adenocarcinoma using Gd-Texaphyrin Oxygen-Loaded Nanodroplets
使用 Gd-Texaphyrin 载氧纳米液滴对缺氧胰腺腺癌进行协同放射增敏
- 批准号:
478914 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:
Operating Grants
Expression mechanism of immune checkpoint molecules after carbon-ion radiotherapy in cervical adenocarcinoma specimens
宫颈腺癌碳离子放疗后免疫检查点分子的表达机制
- 批准号:
23K14913 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Study of fibrosis in pancreatic ductal adenocarcinoma (PDAC) and application of adipose-derived stromal/stem cells for PDAC treatment
胰腺导管腺癌(PDAC)纤维化的研究以及脂肪源性基质/干细胞在 PDAC 治疗中的应用
- 批准号:
23K15035 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
IRAK4 AS A NOVEL IMMUNOTHERAPEUTIC TARGET IN PANCREATIC DUCTAL ADENOCARCINOMA
IRAK4 作为胰腺导管腺癌的新型免疫治疗靶点
- 批准号:
10442874 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:
Therapeutic Targeting of NSD2 in Lung Adenocarcinoma
NSD2 在肺腺癌中的治疗靶向
- 批准号:
10657069 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:
Molecular mechanisms for development of pulmonary invasive mucinous adenocarcinoma
肺浸润性粘液腺癌发生的分子机制
- 批准号:
23H02698 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
- 批准号:
23K08326 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Establishment of histological transformation model from lung small cell carcinoma from adenocarcinoma to explore the therapeutic strategies of small cell lung carcinoma.
建立肺小细胞癌腺癌组织学转化模型,探讨小细胞肺癌的治疗策略。
- 批准号:
23K14614 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms of tumor progression controlled by tumor-initiating cells and cancer-associated fibroblasts in pancreatic adenocarcinoma.
阐明胰腺腺癌中肿瘤起始细胞和癌症相关成纤维细胞控制的肿瘤进展机制。
- 批准号:
23K15075 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidating the Cellular Origins of lung adenocarcinoma
阐明肺腺癌的细胞起源
- 批准号:
10743611 - 财政年份:2023
- 资助金额:
$ 65.19万 - 项目类别:














{{item.name}}会员




